Passer au contenu principal

Votre navigateur n’est malheureusement pas entièrement pris en charge. Si vous avez la possibilité de le faire, veuillez passer à une version plus récente ou utiliser Mozilla Firefox, Microsoft Edge, Google Chrome, ou Safari 14 ou plus récent. Si vous n’y parvenez pas et que vous avez besoin d’aide, veuillez nous faire part de vos commentaires.

Nous vous serions reconnaissants de nous faire part de vos commentaires sur cette nouvelle expérience.Faites-nous part de votre opinionS’ouvre dans une nouvelle fenêtre

Elsevier
Publier avec nous

Early Career Researcher Award Winner

David R. Martinez

DRM

David R. Martinez

Yale University School of Medicine, USA

Early Career Researcher Award Winner

David R. Martinez, Yale University School of Medicine, USA

David R. Martinez, Ph.D. studies immunity to viral pathogens of global health importance. David Martinez received his Ph.D. from Duke University in the laboratory of leading vaccine immunologist, Dr. Sallie Permar. David Martinez trained as a postdoctoral scholar with one the world’s leading coronavirologists, Dr. Ralph Baric, at UNC Chapel Hill before and during the COVID-19 pandemic studying immunity to flaviviruses and coronaviruses. David Martinez was part of the teams that contributed to the development of the FDA-approved and widely used Moderna COVID-19 vaccine. David Martinez also contributed to the pre-clinical development of COVID-19 human monoclonal antibody therapies used in humans. David Martinez is a Hanna Gray Faculty Fellow of the Howard Hughes Medical Institute. In 2023, David Martinez began his laboratory in the Department of Immunobiology at Yale University School of Medicine.